Fedex Issues Statement Regarding Winter Weather

https://newsroom.fedex.com/fedex-statement-regarding-winter-weather  

https://newsroom.fedex.com/fedex-statement-regarding-winter-weather

 

Total
0
Shares
Related Posts
Read More

Cellectar Biosciences Expands A New Licensing Agreement With The Wisconsin Alumni Research Foundation For Intellectual Property That Was The Result Of Collaborative Research With Iopofosine I 131 In Pediatric Cancers

Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced a new licensing

CLRB